Logo image
PD Dr. med. Anne Quante working place, University Hospital Rechts der Isar Munich
PD Dr. med. Anne Quante
Excellent
AiroScore
9.70

PD Dr. med. Anne Quante

genetics gynecology, epidemiology
genetics gynecology, epidemiology
User ScoreExperienceRatingPrice RangeOnline Consultations
98%21 years9.7/10$$$$No

Overview

Country, City
Germany, Munich
Health facility
University Hospital Rechts der Isar Munich
Medical unit
Department of gynaecology, obstetrics, and mammology

About the doctor

Dr. Anne Quante is a highly accomplished medical professional specializing in genetics. With a diverse educational background ranging from medical training to a Master of Public Health degree, Dr. Quante has gained extensive experience in various research and clinical roles. Her career includes positions as a team leader in genetic epidemiology and as a senior physician in human genetics. Dr. Quante's expertise in gynecological tumor genetics and hereditary tumor diseases further showcases her commitment to advancing genetics research and providing specialized patient care. Currently, Dr. Quante works as a Senior Consultant at TUM University Hospital Klinikum rechts der Isar, where she continues to contribute to the field of genetics through her research and clinical practice. With a strong academic foundation and years of experience in leading roles, Dr. Quante is recognized for her contributions to genetic epidemiology and hereditary tumor diseases. Patients benefit from her in-depth knowledge and dedication to advancing genetic research, making her a valuable asset to the medical community.

Resume

CV (Curriculum Vitae)

Education
  • 1997-2004 Medical examination and license to practice medicine, Albert Ludwig University of Freiburg im Breisgau
  • 2003-2005 Promotion in Internal Medicine, Albert Ludwig University of Freiburg im Breisgau
  • 2008-2010 Master of Public Health - MPH Epidemiolog, Columbia University in the City of New York
  • 2011-2019 Habilitation in the field of epidemiology Genetic Epidemiology, Ludwig Maximilian University of Munich
Experience
  • 2005-2010 Assistant Doctor of Human Genetics, Heinrich
  • 2010-2011 Research Assistant, Columbia University in the City of New York
  • 2011-2017 Team leader and research assistant, Ludwig Maximilian University of Munich
  • 2021-2022 Senior physician in human genetics, University Hospital Freiburg
  • 2017-2020 Senior physician and head of gynecological tumor genetics, the TUM Klinikum Rechts der Isar
  • 2017-2024 Head of the Gynecological Tumor Genetics Group, the TUM Klinikum Rechts der Isar
  • 2023-2024 Head of Hereditary Tumor Diseases at the SYNLAB Holding Deutschland GmbH
  • 2024 Senior Consultant, TUM University Hospital Klinikum rechts der Isar

Languages

English flag
English
German flag
German

Location

Ismaninger Str., 22, 81675 Munich, Germany

FAQ

What is the specialization of PD Dr. med. Anne Quante?

The primary specialization of the doctor is genetics gynecology, epidemiology.

What is the experience of the specialist?

PD Dr. med. Anne Quante has been practicing for more than 21 years.

What is the rating of the doctor?

Does the specialist offer online consultations?

No, PD Dr. med. Anne Quante doesn’t perform virtual appointments.

PD Dr. med. Anne Quante
PD Dr. med. Anne Quante

Get individual treatment plan and cost estimate. Non-binding 100% free assessment.

© PD Dr. med. Anne Quante

Similar Doctors

Excellent
AiroScore
9.90
University Hospital Rechts der Isar Munich
obstetrics and perinatal medicine, medical genetics
Excellent
AiroScore
9.80
University Hospital Ludwig-Maximilians Munich
gynecology and obstetrics, gynecological oncology
Excellent
AiroScore
9.80
University Hospital Rechts der Isar Munich
operative gynecology, fetal surgery, obstetrics and perinatal medicine
Excellent
AiroScore
9.70
Excellent
AiroScore
9.70
Academic Hospital Harlaching Munich
obstetrics, gynecology, gynecological oncology, minimally invasive surgery
Excellent
AiroScore
9.70
University Hospital Rechts der Isar Munich
breast surgery, gynecological drug tumor therapy